Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 6 47-6, 2003, Pages

  Tardif, Annie ^a   Julien, Nathalie ^a   Chiasson, Jean Louis ^a   Coderre, Lise ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Diabetes; Heart; Insulin signaling; Phosphatidylinositol 3 kinase; Protein kinase B Akt; Vanadium

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VANADIC ACID; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; GLUCOSE TRANSPORT; HEART CELL CULTURE; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0037502905     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00134.2002     Document Type: Article

References (50)

1. Aharon Y, Mevorach M, and Shamoon H. Vanadyl sulfate does not enhance insulin action in patients with type 1 diabetes. Diabetes Care 21: 2194-2195, 1998.
2. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, and Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551, 1996.
3. Backer JM, Myers MCJ, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, and White MF. Phosphatidylinositol 3′ T-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11: 3469-3479, 1992.
4. Belke DD, Larsen TS, Gibbs EM, and Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 279: E1104-E1113, 2000.
5. Boden G, Chen X, Ruiz J, van Rossum GD, and Turco S. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 45: 1130-1135, 1996.
6. Brichard SM, Assimacopoulos-Jeannet F, and Jeanrenaud B. Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression. Endocrinology 131: 311-317, 1992.
7. Cam MC, Brownsey RW, Rodrigues B, and McNeill JH. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats. Metabolism 50: 674-680, 2001.
8. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, Kaestner KH III, Bartolomei MS, Shulman GI, and Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731, 2001.
9. Cortright RN, Azevedo JL Jr, Hickey MS, Tapscott EB, and Dohm GL. Vanadate stimulation of 2-deoxyglucose transport is not mediated by PI 3-kinase in human skeletal muscle. Biochim Biophys Acta 1358: 300-306, 1997.
10. Cusi K, Cukier S, DeFronzo RA, Torres M, Puchulu FM, and Redondo JC. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes. J Clin Endocrinol Metab 86: 1410-1417, 2001.
11. Donthi RV, Huisamen B, and Lochner A. Effect of vanadate and insulin on glucose transport in isolated adult rat cardiomyocytes. Cardiovasc Drugs Ther 14: 463-470, 2000.
12. Enrique-Tarancon G, Castan I, Morin N, Marti L, Abella A, Camps M, Casamitjana R, Palacin M, Testar X, Degerman E, Carpene C, and Zorzano A. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells. Biochem J 350: 171-180, 2000.
13. Garvey WT, Hardin D, Juhaszova M, and Dominguez JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 264: H837-H844, 1993.
14. Hajduch E, Alessi DR, Hemmings BA, and Hundal RS. Constitutive activation of protein kinase Bα by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47: 1006-1013, 1998.
15. Huang C, Zhang Z, Ding M, Li J, Ye J, Leonard SS, Shen HM, Butterworth L, Lu Y, Costa M, Rojanasakul Y, Castranova V, Vallyathan V, and Shi X. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J Biol Chem 275: 32516-32522, 2000.
16. Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, and Ramachandran C. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervannadate. J Biol Chem 272: 843-851, 1997.
17. Kohn AD, Summers SC, Birnbaum MJ, and Roth RA. Expression of a constitutively active Akt; Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378, 1996.
18. Kraegen EW, Sowden JA, Halstead MB, Clark PW, Rodnick KJ, Chisholm DJ, and James DE. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. Biochem J 295: 287-293, 1993.
19. Leighton B, Cooper GJ, DaCosta C, and Foot EA. Peroxovanadates have full insulin-like effects on glycogen synthesis in normal and insulin-resistant skeletal muscle. Biochem J 276: 289-292, 1991.
20. Lu B, Ennis D, Lai R, Bogdanovic E, Nikolov R, Salamon L, Fantus C, Le Tien H, and Fantus IG. Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). J Biol Chem 276: 35589-35598, 2001.
21. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, and Goldstein BJ. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276: 48662-48669, 2001.
22. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulinstimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase lb in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
23. Marti L, Abella A, Carpene C, Palacin M, Testar X, and Zorzano A. Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats. Diabetes 50: 2061-2068, 2001.
24. Marti L, Morin N, Enrique-Tarancon G, Prevot D, Lafontan M, Testar X, Zorzano A, and Carpene C. Tyramine and vanadate synergistically stimulate glucose transport in rat adipocytes by amine oxidase-dependent generation of hydrogen peroxide. J Pharmacol Exp Ther 285: 342-349, 1998.
25. Meyer C and Schwaiger M. Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol 80: 94A-101A, 1997.
26. Myers MG and White MF. The new elements of insulin signaling insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42: 643-650, 1993.
27. Okada T, Kawano Y, Sakakibara T, Hazeki O, and Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269: 3568-3573, 1994.
28. Pandey SK, Anand-Srivastava MB, and Srivastava AK. Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase (PI3-K) and is independent of insulin receptor tyrosine phosphorylation. Biochemistry 37: 7006-7014, 1998.
29. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, and Kahn BB. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865-870, 1990.
30. Rao V. Editorial comment: glucose transporter upregulation. Circulation 98: II-240-II-241, 1998.
31. Sekar N, Li J, and Shechter Y. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Crit Rev Biochem Mol Biol 31: 339-359, 1996.
32. Shao J, Catalano PM, Yamashita H, Ishizuka T, and Friedman JE. Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus. Am J Obstet Gynecol 183: 1263-1270, 2000.
33. Sharma PM, Egawa K, Huang Y, Martin JL, Huvar I, Boss GR, and Olefsky JM. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J Biol Chem 273: 18528-18537, 1998.
34. Somwar R, Koterski S, Sweeney G, Sciotti R, Djuric S, Berg C, Trevillyan J, Scherer PE, Rondinone CM, and Klip A. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J Biol Chem 277: 50386-50395, 2002.
35. Somwar R, Niu W, Kim DY, Sweeney G, Randhawa VK, Huang C, Ramlal T, and Klip A. Differential effects of phosphatidylinositol 3-kinase inhibition on intracellular signals regulating GLUT4 translocation and glucose transport. J Biol Chem 276: 46079-46087, 2001.
36. Somwar R, Perreault M, Kapur S, Taha C, Sweeney G, Ramlal T, Kim DY, Keen J, Cote CH, Klip A, and Marette A. Activation of p38 mitogen-activated protein kinase a and β by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport. Diabetes 49: 1794-1800, 2000.
37. Srivastava AK. Potential use of vanadium compounds in the treatment of diabetes mellitus. Exp Opin Invest Drugs 4: 525-536, 1995.
38. Strout HV, Vicario PP, Biswas C, Superstein R, Brady EJ, Pilch PF, and Berger J. Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle. Endocrinology 126: 2728-2732, 1990.
39. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, and White MF. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352: 73-77, 1991.
40. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, and Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274: 10071-10078, 1999.
41. Takeuchi K, McGowan FX Jr, Glynn P, Moran AM, Rader CM, Cao-Danh H, and del Nido PJ. Glucose transporter upregulation improves ischemic tolerance in hypertrophied failing heart. Circulation 98: II-234-II-241, 1998.
42. Tardif A, Julien N, Pelletier A, Thibault G, Srivastava AK, Chiasson JL, and Coderre L. Chronic exposure to β-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. Am J Physiol Endocrinol Metab 281: E1205-E1212, 2001.
43. Tsiani E, Bogdanovic E, Sorisky A, Nagy L, and Fantus IG. Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. Diabetes 47: 1676-1686, 1998.
44. Ueki K, Yamamoto-Honda R, Kaburagi Y, Yamauchi T, Tobe K, Burgering BM, Coffer PJ, Komuro I, Akanuma Y, Yazaki Y, and Kadowaki T. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273: 5315-5322, 1999.
45. Voipio-Pulkki LM, Nuutila P, Knuuti MJ, Ruotsalainen U, Haaparanta M, Teras M, Wegelius U, and Koivisto VA. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med 34: 2064-2067, 1993.
46. Wijkander J, Holst LS, Rahn T, Resjo S, Castan I, Manganiello V, Belfrage P, and Degerman E. Regulation of protein kinase B in rat adipocytes by insulin, vanadate, and peroxovanadate. Membrane translocation in response to peroxovanadate. J Biol Chem 272: 21520-21526, 1997.
47. Willsky GR, Goldfine AB, Kostyniak PJ, McNeill JH, Yang LQ, Khan HR, and Crans DC. Effect of vanadium (IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis (maltolato) oxovanadium (IV). J Inorg Biochem 85: 33-42, 2001.
48. Yenush L and White MF. The IRS-signalling system during insulin and cytokine action. BioAssays 19: 491-500, 1997.
49. Yuen VG, Orvig C, Thompson KH, and McNeill JH. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis (maltolato) oxo-vanadium (IV). Can J Physiol Pharmacol 71: 270-276, 1993.
50. Zorzano A, Sevilla L, Camps M, Becker C, Meyer J, Kammermeier H, Munoz P, Gumà A, Testar X, Palacin M,Blasi J, and Fischer Y. Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. Am J Cardiol 80: 65A-76A, 1997.